KPIs & Operating Metrics(New)
Growth Metrics

Cvs Health (CVS) EBITDA Margin (2016 - 2025)

Cvs Health's EBITDA Margin history spans 17 years, with the latest figure at 0.3% for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA Margin rose 126.0% year-over-year to 0.3%, compared with a TTM value of 1.19% through Dec 2025, down 1195.0%, and an annual FY2025 reading of 0.56%, down 637.0% over the prior year.
  • EBITDA Margin for Q4 2025 was 0.3% at Cvs Health, down from 1.87% in the prior quarter.
  • The five-year high for EBITDA Margin was 51.28% in Q4 2023, with the low at 2.39% in Q4 2022.
  • Average EBITDA Margin over 5 years is 4.84%, with a median of 1.44% recorded in 2025.
  • Year-over-year, EBITDA Margin soared 5367bps in 2023 and then tumbled -5283bps in 2024.
  • Tracing CVS's EBITDA Margin over 5 years: stood at 1.68% in 2021, then crashed by -42bps to 2.39% in 2022, then skyrocketed by 2248bps to 51.28% in 2023, then plummeted by -103bps to 1.56% in 2024, then soared by 81bps to 0.3% in 2025.
  • Per Business Quant, the three most recent readings for CVS's EBITDA Margin are 0.3% (Q4 2025), 1.87% (Q3 2025), and 2.41% (Q2 2025).